COMETS - Compare the Efficacy of Rosuvastatin With Atorvastatin and Placebo in the Treatment of Non-Diabetic, Non-Atheroscleric, Metabolic Syndrome Subjects

This study has been completed.

Study NCT00654485 Information provided by AstraZeneca

First Received: April 3, 2008 Last Updated: March 13, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	February 2005
Estimated Primary Completion Date:	No date given